Prolactin as a possible predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)

被引：0
|
作者：
Caponnetto, S. [1 ]
Mancini, M. L. [1 ]
Scagnoli, S. [1 ]
Barchiesi, G. [1 ]
Mosillo, C. [1 ]
Iannantuono, G. M. [1 ]
Verkhovskaia, S. [1 ]
Magri, V. [1 ]
Piesco, G. [1 ]
Pomati, G. [1 ]
Pellegrino, D. [1 ]
Urbano, F. [1 ]
Zancla, S. [1 ]
Manai, C. [1 ]
Cortesi, E. [1 ]
机构：
[1] Sapienza Univ Roma, Policlin Umberto 1, Oncol Med B, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw332.36
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A36
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)
    Caponnetto, S.
    Mancini, M.
    Manai, C.
    Magri, V.
    Iannantuono, G. M.
    Pellegrino, D.
    Mosillo, C.
    Piesco, G.
    Pomati, G.
    Scagnoli, S.
    Urbano, F.
    Verkhovskaya, S.
    Barchiesi, G.
    Zancla, S.
    Cortesi, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Caponnetto, Salvatore
    Iannantuono, Giovanni Maria
    Barchiesi, Giacomo
    Magri, Valentina
    Gelibter, Alain
    Cortesi, Enrico
    ONCOLOGY, 2017, 93 (01) : 62 - 66
  • [3] Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo).
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Helias-Rodzewicz, Zofia
    Dumoulin, Jennifer
    Giraud, Violaine
    Labrune, Sylvie
    Chinet, Thierry
    Emile, Jean-Francois
    Giroux-Leprieur, Etienne
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
    Costantini, Adrien
    Corny, Jennifer
    Fallet, Vincent
    Renet, Sophie
    Friard, Sylvie
    Chouaid, Christos
    Duchemann, Boris
    Giroux-Leprieur, Etienne
    Taillade, Laurent
    Doucet, Ludovic
    Nguenang, Marina
    Jouveshomme, Stephane
    Wislez, Marie
    Tredaniel, Jean
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [5] Predictive and prognostic value of systemic inflammatory response biomarkers in patients receiving nivolumab for metastatic non-small cell lung cancer (NSCLC).
    Gervais, Claire
    Boudou-Rouquette, Pascaline
    Jouinot, Anne
    Huillard, Olivier
    Alexandre, Jerome
    Arrondeau, Jennifer
    Giraud, Frederique
    Chapron, Jeanne
    Alifano, Marco
    Revel, Marie-Pierre
    Dusser, Daniel
    Damotte, Diane
    Mansuet-Lupo, Audrey
    Goldwasser, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Hyponatraemia as an unrecognised risk factor in non-small cell lung cancer (NSCLC) treatment with nivolumab.
    Grohe, Christian
    Gwynn, Simon
    Evans, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [8] Body composition as predictor of toxicity and outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) receiving nivolumab (Nivo).
    Shachar, Shlomit Strulov
    Fried, Rachel
    Shafran, Itamar
    Moskovitz, Mor Tal
    Williams, Grant Richard
    Bar-Sela, Gil
    Reiner-Benaim, Anat Strulov
    Wollner, Mira
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Predictive biomarkers in the treatment of non-small cell lung cancer (NSCLC)
    Niho, Seiji
    CANCER SCIENCE, 2018, 109 : 423 - 423
  • [10] Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC)
    Hellmann, M. D.
    Rizvi, N.
    Gettinger, S. N.
    Goldman, J.
    Chow, L. Q.
    Juergens, R.
    Borghaei, H.
    Brahmer, J.
    Shen, Y.
    Harbison, C. T.
    Nathan, F.
    Ready, N. E.
    Antonia, S. J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S632 - S633
12345